Merus N.V. (MRUS) DCF Valuation
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
Merus N.V. (MRUS) Bundle
Evaluate Merus N.V.'s (MRUS) financial outlook with expert precision! This (MRUS) DCF Calculator comes with pre-filled financial data and offers you the complete flexibility to modify revenue growth, WACC, margins, and other critical assumptions to align with your projections.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 32.5 | 31.2 | 51.2 | 43.4 | 45.8 | 51.6 | 58.1 | 65.5 | 73.7 | 83.1 |
Revenue Growth, % | 0 | -3.82 | 64 | -15.32 | 5.68 | 12.64 | 12.64 | 12.64 | 12.64 | 12.64 |
EBITDA | -51.8 | -63.5 | -81.0 | -154.5 | -155.5 | -51.6 | -58.1 | -65.5 | -73.7 | -83.1 |
EBITDA, % | -159.55 | -203.49 | -158.32 | -356.51 | -339.52 | -100 | -100 | -100 | -100 | -100 |
Depreciation | 1.2 | 1.5 | 1.5 | 1.3 | 2.6 | 2.1 | 2.4 | 2.7 | 3.0 | 3.4 |
Depreciation, % | 3.66 | 4.82 | 3.02 | 3.09 | 5.78 | 4.07 | 4.07 | 4.07 | 4.07 | 4.07 |
EBIT | -53.0 | -65.0 | -82.6 | -155.9 | -158.2 | -51.6 | -58.1 | -65.5 | -73.7 | -83.1 |
EBIT, % | -163.21 | -208.31 | -161.35 | -359.6 | -345.3 | -100 | -100 | -100 | -100 | -100 |
Total Cash | 249.9 | 216.6 | 427.8 | 302.5 | 370.2 | 51.6 | 58.1 | 65.5 | 73.7 | 83.1 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | 3.0 | 1.8 | 7.0 | 4.9 | 4.1 | 5.1 | 5.7 | 6.4 | 7.2 | 8.2 |
Account Receivables, % | 9.35 | 5.84 | 13.59 | 11.3 | 9.06 | 9.83 | 9.83 | 9.83 | 9.83 | 9.83 |
Inventories | .0 | 7.7 | 5.1 | 9.7 | .0 | 5.9 | 6.6 | 7.5 | 8.4 | 9.5 |
Inventories, % | 0.000003212026 | 24.82 | 9.99 | 22.39 | 0 | 11.44 | 11.44 | 11.44 | 11.44 | 11.44 |
Accounts Payable | 3.2 | 3.3 | 13.8 | 10.3 | 4.8 | 8.4 | 9.4 | 10.6 | 12.0 | 13.5 |
Accounts Payable, % | 9.73 | 10.44 | 26.96 | 23.65 | 10.47 | 16.25 | 16.25 | 16.25 | 16.25 | 16.25 |
Capital Expenditure | -2.7 | -1.3 | -.9 | -8.0 | -4.2 | -4.3 | -4.9 | -5.5 | -6.2 | -7.0 |
Capital Expenditure, % | -8.34 | -4.3 | -1.77 | -18.37 | -9.06 | -8.37 | -8.37 | -8.37 | -8.37 | -8.37 |
Tax Rate, % | -2.1 | -2.1 | -2.1 | -2.1 | -2.1 | -2.1 | -2.1 | -2.1 | -2.1 | -2.1 |
EBITAT | -53.2 | -65.4 | -82.9 | -157.0 | -161.5 | -51.6 | -58.1 | -65.5 | -73.7 | -83.1 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -54.6 | -71.7 | -74.2 | -169.7 | -158.0 | -57.1 | -60.9 | -68.6 | -77.3 | -87.1 |
WACC, % | 9.73 | 9.73 | 9.73 | 9.73 | 9.73 | 9.73 | 9.73 | 9.73 | 9.73 | 9.73 |
PV UFCF | ||||||||||
SUM PV UFCF | -262.6 | |||||||||
Long Term Growth Rate, % | 2.00 | |||||||||
Free cash flow (T + 1) | -89 | |||||||||
Terminal Value | -1,149 | |||||||||
Present Terminal Value | -722 | |||||||||
Enterprise Value | -985 | |||||||||
Net Debt | -201 | |||||||||
Equity Value | -784 | |||||||||
Diluted Shares Outstanding, MM | 52 | |||||||||
Equity Value Per Share | -15.19 |
What You Will Get
- Real Merus N.V. Data: Preloaded financials – from revenue to EBIT – based on actual and projected figures.
- Full Customization: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- Instant Valuation Updates: Automatic recalculations to analyze the impact of changes on Merus N.V.’s fair value.
- Versatile Excel Template: Tailored for quick edits, scenario testing, and detailed projections.
- Time-Saving and Accurate: Skip building models from scratch while maintaining precision and flexibility.
Key Features
- 🔍 Real-Life MRUS Financials: Pre-filled historical and projected data for Merus N.V.
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate Merus’s intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize Merus’s valuation instantly after making changes.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- Download: Obtain the comprehensive Excel file containing Merus N.V. (MRUS) financial data.
- Customize: Modify forecasts such as revenue growth, EBITDA %, and WACC to fit your analysis.
- Update Automatically: Watch as intrinsic value and NPV calculations refresh in real-time.
- Test Scenarios: Generate various projections and evaluate results immediately.
- Make Decisions: Leverage the valuation findings to inform your investment strategy.
Why Choose This Calculator for Merus N.V. (MRUS)?
- Comprehensive Tool: Integrates DCF, WACC, and financial ratio analyses tailored for Merus N.V. (MRUS).
- Customizable Inputs: Modify yellow-highlighted cells to explore different financial scenarios.
- Detailed Insights: Automatically computes Merus N.V. (MRUS)’s intrinsic value and Net Present Value.
- Preloaded Data: Historical and projected data provide reliable starting points for analysis.
- Professional Quality: Perfect for financial analysts, investors, and business consultants focusing on Merus N.V. (MRUS).
Who Should Use This Product?
- Finance Students: Explore valuation methods and apply them to real-world data related to Merus N.V. (MRUS).
- Academics: Integrate advanced financial models into your studies or research focused on biotechnology.
- Investors: Evaluate your investment strategies and analyze the valuation metrics for Merus N.V. (MRUS).
- Analysts: Enhance your analysis process with a customizable DCF model tailored for biopharmaceutical companies.
- Biotech Entrepreneurs: Understand how publicly traded companies like Merus N.V. (MRUS) are valued in the market.
What the Template Contains
- Preloaded MRUS Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
- DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
- Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
- Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
- Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
- Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.